Rockefeller Capital Management
CDMO

Rockefeller Capital Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Rockefeller Capital Management’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-19
Closed – – 3993
2022
Q4 		$0 Hold
19
– – ﹤0.01% 4281
2022
Q3 		$0 Sell
19
-35
-65% -$638 ﹤0.01% 4469
2022
Q2 		$0 Hold
54
– – ﹤0.01% 4450
2022
Q1 		$1K Buy
+54
New +$1.1K ﹤0.01% 3801

Other funds holding CDMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Rockefeller Capital Management's CDMO Position: Q1 2023 in Review

Rockefeller Capital Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2023, closing a stake of 19 shares.

Rockefeller Capital Management first reported a position in CDMO in Q1 2022 and held it in 4 quarters. The position peaked at $1K in Q1 2022. 168 funds tracked by Wall St. Rank hold CDMO as of Q1 2023.

  • Rockefeller Capital Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Rockefeller Capital Management sold 19 Avid Bioservices, Inc. Common Stock shares in Q1 2023.
  • Rockefeller Capital Management first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
  • Rockefeller Capital Management's Avid Bioservices, Inc. Common Stock position peaked at $1K in Q1 2022.
  • 168 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2023.

Based on Rockefeller Capital Management's 13F filing for Q1 2023, filed 16 May 2023.